VASP and breast carcinoma: In addition, whereas ENAH and VASP promote the invasive potential of migratory breast cancer cells, EVL suppresses breast cancer invasion (Roussos et al., 2010; Zhang et al., 2009; Padilla-Rodriguez et al., 2018).